Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of inpatient electroencephalography on clinical decision making.

The Journal of the American Osteopathic Association·2013

Same author

Effect of vitamin D replacement on insulin sensitivity in subjects with vitamin D deficiency.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2012

Same author

Common patient concerns about the use of glucagon-like peptide-1 receptor agonists in diabetes mellitus management.

The Journal of the American Osteopathic Association·2012

Same author

Incorporating glucagon-like peptide-1 receptor agonists into clinical practice.

The Journal of the American Osteopathic Association·2012

Same author

Diabetes--it's the basics that count.

The Journal of the American Osteopathic Association·2011

Same author

Pharmacology of GLP-1 agonists: describing the therapeutic potential to patients.

The Journal of the American Osteopathic Association·2011

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.

Craig W Spellman¹

¹Department of Internal Medicine, Texas Tech University Health Sciences Center, Odessa, TX 79763-4206, USA. craig.spellman@ttuhsc.edu

The Journal of the American Osteopathic Association

|April 13, 2010

Summary

Type 2 diabetes mellitus (T2DM) is a global health issue. New incretin-based therapies improve insulin secretion and reduce glucagon production, offering new management strategies for hyperglycemia.

More Related Videos

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Related Experiment Videos

Last Updated: Jun 14, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Lepr^db Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Area of Science:

Endocrinology and Metabolism
Genetics and Genomics

Background:

Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder characterized by hyperglycemia.
Pathophysiology involves insufficient insulin secretion, peripheral insulin resistance, and inadequate glucagon suppression, leading to impaired glucose regulation.
Genetic polymorphisms in multiple genes, not a single gene mutation, are increasingly recognized as key risk factors for T2DM.

Purpose of the Study:

To review the pathophysiology of T2DM.
To discuss the genetic underpinnings of T2DM.
To highlight emerging therapeutic strategies for T2DM management.

Main Methods:

Literature review of T2DM pathophysiology.
Analysis of genetic research on T2DM etiology.
Evaluation of current and emerging T2DM treatment modalities.

Main Results:

T2DM is characterized by complex metabolic dysregulation and hyperglycemia.
Polygenic inheritance significantly contributes to T2DM risk.
Incretin-based agents represent a promising therapeutic avenue.

Conclusions:

Understanding T2DM pathophysiology and genetics is crucial for effective management.
Emerging therapies like incretin-based agents offer targeted approaches to improve glycemic control.
Continued research into genetic factors and novel treatments is essential for combating the T2DM epidemic.